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ABSTRACT 
Background and Objectives: Recent studies have demonstrated the usefulness of biochemical markers of collagen 
turnover as markers of myocardial fibrosis in various diseases. In this study, we hypothesized that increased col-
lagen markers in patients with hypertrophic cardiomyopathy (HCM) were correlated with diastolic function at 
rest and diastolic functional reserve during exercise. Subjects and Methods: Thirty-six patients with HCM and 
21 controls with normal left ventricular thickness were studied. Mitral septal annular velocities and mitral in-
flow velocities were measured at rest and during graded supine bicycle exercise (25 W, 3-minute increments) for 
the assessment of diastolic function at rest and during exercise. By radioimmunoassay, a byproduct of collagen III 
synthesis (PIIINP) and peptides resulting from collagen I synthesis (PINP) and degradation (ICTP) were measured. 
The patients with HCM were divided into two groups according to the median value of the PINP/ICTP ratio in 
the group. Results: At rest, the mitral annular early diastolic velocity (E’) was lower and the E/E’ was higher in the 
patients with HCM with high a PINP/ICTP ratio compared with patients with HCM with a low PINP/ICTP ra-
tio and controls (p<0.001, p=0.012). With exercise, the Doppler parameters were increased in all groups, but 
there was no significant difference in the change in E’ and E/E’ during exercise according to collagen turnover 
markers. Conclusion: A higher PINP/ICTP ratio was associated with resting diastolic dysfunction in patients with 
HCM; however, there was no relationship with augmented diastolic dysfunction during exercise. We suggest that 
the type I collagen synthesis-to-degradation ratio is a useful marker of resting diastolic function in patients with 
HCM. (Korean Circ J 2009;39:519-524) 
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Introduction 
 
The pathophysiology of hypertrophic cardiomyopathy 
(HCM) is complex, with structural, hemodynamic, and 
arrhythmic processes contributing to the symptoms and 
natural history in this disorder. However, the most im-
portant pathophysiologic features of HCM is diastolic 
dysfunction and a decrease in left ventricular compliance. 
Thus, HCM is regarded as the most representative dis-
ease of left ventricular diastolic dysfunction.
1)2) The his-
topathologic findings of HCM are myocardial hypertro-
phy, and interstitial fibrosis and disarray. Previous studies 
based on autopsies have shown that the degree of myo-
cardial fibrosis is severe and varies as compared with my-
ocardium obtained from normotensive or hypertensive 
patients.
3) In recent years, several studies have been con-
ducted to quantify the myocardial fibrosis and have re-
ported that serum biochemical markers, which are syn-
thesized by the production and degradation of matrix 
collagen, are elevated in subjects with hypertensive myo-
cardial hypertrophy and HCM relating to the myocardial 
fibrosis.
4-6) It has also been suggested that serum bioche-
mical markers are associated with diastolic dysfunction.
7-10) 
The most common symptom of HCM is shortness of 
Received: January 9, 2009 
Revision Received: May 6, 2009 
Accepted: May 19, 2009 
Correspondence: Jong-Won Ha, MD, Division of Cardiology, Cardiovascular
Center, Yonsei University College of Medicine, 250 Seongsan-ro, Seodae-
mun-gu, Seoul 120-752, Korea 
Tel: 82-2-2228-8448, Fax: 82-2-2227-7943 
E-mail: jwha@yuhs.ac 
 
  ○  cc This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,
distribution, and reproduction in any medium, provided the original work is
properly cited. 
  
 
520·Collagen Markers and Hypertrophic Cardiomyopathy 
 
breath and it is usually aggravated by exercise.
1) Diastolic 
dysfunction seems to be the most important determinant 
of exercise capacity in patients with HCM. In HCM, the 
limited capability of increasing left ventricular end-di-
astolic volume, especially during exercise at high heart 
rates, implies an inadequate increase in stroke volume.
11) 
Such a lack of increase in stroke volume is accompanied 
by a leftward shift of the left ventricular diastolic pres-
sure-volume relation during exercise.
11)12) Specifically, bas-
ed on a few studies which were conducted using exercise 
Doppler echocardiography, it has been demonstrated that 
left ventricular diastolic reserve, systolic reserve, and ex-
ercise tolerance are decreased in patients with HCM.
13)14) 
However, there are many differences in exercise capacity 
and symptoms of heart failure, although there is a simi-
lar extent of myocardial hypertrophy or the left ventric-
ular dimension in patients with HCM. Thus, we can hy-
pothesize that the degree of myocardial fibrosis might be 
associated with the left ventricular reserve and exercise 
tolerance. To prove our hypothesis, we sought to assess 
diastolic function not only at rest, but also with exercise 
by using exercise Doppler echocardiography in patients 
with HCM. To quantify the amount of myocardial fibro-
sis, serum biochemical markers which are involved in 
collagen metabolism were analyzed. We then examined 
the relationship between serum biochemical markers of 
myocardial fibrosis and diastolic function at rest and with 
exercise in patients with HCM. 
 
Subjects and Methods 
 
Subjects 
The study population was comprised of 36 patients 
with HCM (20 males; mean age, 57±10 years; 31 pa-
tients with non-obstructive HCM) and 21 age- and gen-
der-matched control subjects with normal left ventric-
ular thickness. The subjects with left ventricular systolic 
dysfunction (left ventricular ejection fraction <55%), 
significant valvular disease, arrhythmia, coronary artery 
disease, or renal insufficiency (serum creatinine >1.4 
mg/mL) were excluded. Each subject provided informed, 
written consent to the protocol that had been approved 
by our Institutional Review Board. 
The ratio between procollagen type I N-terminal pep-
tide (PINP) and collagen type I pyridinoline cross-linked 
C-terminal telopeptide (ICTP), PINP/ICTP, which is 
known as the degree of synthesis and degradation of type 
I collagen, was 9.1±7.8 in the control group and 10.9±
6.5 in the HCM group. Patients with HCM (n=36) were 
divided into the following two groups based on the me-
dian value of the PINP/ICTP: the lower group (PINP/ 
ICTP < median value; n=18; 10 males) and the higher 
group (PINP/ICTP≥median value; n=18; 10 males) for 
analysis. A comparison was made between the 3 groups 
(the control group, the HCM group with a lower PINP/ 
ICTP, and the HCM group with a higher PINP/ICTP). 
 
Two-dimensional and exercise doppler echocardi-
ography (diastolic stress echocardiography) 
Standard 2-dimensional measurements (left ventric-
ular diastolic and systolic dimensions, ventricular sep-
tum and posterior wall thickness, left atrial volume, and 
left ventricular outflow tract) were obtained with the sub-
jects in the left decubitus position. The left ventricular 
ejection fraction was calculated by the modified method 
of Quinones et al.
15) After obtaining the rest images from 
the standard parasternal and apical views, a multistage 
supine bicycle exercise testing was performed with a var-
iable load bicycle ergometer (Medical Positioning Inc., 
Kansas City, MO, USA). Subjects pedaled at constant 
speed beginning at a workload of 25 W with an incre-
ment of 25 W every 3 minutes. Echocardiography was 
performed using an ultrasound system (System 7; GE 
Vingmed, Horten, Norway) with a 2.5-MHz transducer 
during rest, each stage of exercise, and recovery in the se-
quence described as follows. From the apical window, a 
1-2-mm pulsed Doppler sample volume was placed at 
the mitral valve tip, and mitral flow velocities from 5-10 
cardiac cycles were recorded. The mitral inflow velocities 
were traced and the following variables were obtained: 
peak velocity of early (E) and late (A) filling, and decel-
eration time of the E wave velocity. Tricuspid regurgitant 
jet velocity was also obtained to estimate pulmonary ar-
tery systolic pressure using continuous wave Doppler, if 
measurable. Mitral annular velocity was measured by 
Doppler tissue imaging using the pulsed wave Doppler 
mode. The filter was set to exclude high-frequency sig-
nals, and the Nyquist limit was adjusted to a range of 15-
20 cm/s. Gain and sample volume were minimized to 
allow for a clear tissue signal with minimal background 
noise. E’ and systolic (S’) velocities of the mitral annulus 
were measured from the apical 4-chamber view with a 
2-5-mm sample volume placed at the septal corner of the 
mitral annulus. Stroke volume (SV) was measured from 
the left ventricular outflow tract diameter and the pulse 
wave Doppler signal, as previously described.
16) To pro-
vide a continuous variable that might estimate Ed, the 
E/E’ ratio was used as an estimation of mean left atrial 
pressure. Operant Ed was estimated as E/E’ divided by 
the volume SV of filling during diastole, based on a pre-
vious study.
17) These measurements were performed at 
baseline, at each stage of exercise, and recovery in the 
same sequence. All data were stored digitally and meas-
urements were made at the completion of each study. 
 
Serologic markers of collagen metabolism 
To assess collagen markers, we measured serum levels 
of peptides released during collagen synthesis and degra-
dation. Peripheral venous blood samples were centrifug-
ed at 4℃. Aliquots of serum were immediately stored at  
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-70℃ until the assay.  
The measurement of serum PINP, procollagen type III 
amino terminal peptide (PIIIINP), and ICTP was per-
formed using a commercially available radioimmunoas-
say (Farmos Diagnostica, Oulu, Finland), all of which were 
indicators reflecting collagen synthesis and degradation. 
The accuracy of this method has been reported to have 
an inter- and intra-assay variation <10%. 
 
Statistical analysis 
All the results were expressed as the mean±standard 
deviation. To compare the categorical variables, a chi-
square test was used. For comparison of the continuous 
variables, analysis of variance (ANOVA) was performed. 
Serum biochemical markers indicating myocardial fibro-
sis did not follow a normal distribution, which were con-
verted to logarithms for statistical analysis. Statistical sig-
nificance was defined as <.05. Statistical analysis was per-
formed using Statistical Package for Social Science (SPSS) 
13.0 for Windows (SPSS, Inc., Chicago, IL, USA).  
 
Results 
 
Clinical characteristics of the study subjects 
The baseline characteristics of clinical variables and 
serum collagen markers are shown in Table 1. The age 
and gender distribution was not different between the 
three groups. The left ventricular end-diastolic and end-
systolic dimensions were significantly lower in the HCM 
group, especially in the HCM group with a higher PINP/ 
ICTP ratio. The myocardial thickness of the interventri-
cular septum and posterior wall were increased in the 
HCM group. The HCM group had a significantly larger 
left ventricular volume index, but there were no differ-
ences in the left ventricular systolic function. There were 
no significant differences in the duration of exercise be-
tween the three groups. Of the serum biochemical mark-
ers indicating myocardial fibrosis, the log PINP and log 
PINP/ICTP were significantly higher in the HCM group. 
Furthermore, the patients with HCM with a higher PI-
NP/ICTP ratio had significantly higher levels of log PI-
NP and log PINP/ICTP due to the study design. 
 
Hemodynamic variables at rest and with exercise 
The changes in systolic blood pressure, diastolic blood 
pressure, and heart rate during exercise are shown in Ta-
ble 2. In the three groups, the blood pressure and heart 
rate were increased gradually during exercise; however, 
there were no significant differences between the three 
groups in hemodynamic variables at rest and with exercise. 
Table 1. Baseline characteristics of control and HCM patients
HCM (n=36) 
  Control (n=21) 
Low PINP/ICTP (n=18)  High PINP/ICTP (n=18) 
p 
Age (years)  57.8±11.6 55.9±11.5 58.3±9.0  <0.784
Gender (M : F) 11  : 10 10  : 8 10  : 8  <0.973
Height (cm)  162.9±6.6 164.4±7.7 161.2±7.8  <0.471
Weight (kg)  65.3±9.5 66.3±9.7 63.3±9.1  <0.625
BSA (m
2) 1.71±0.15 1.74±1.16 1.68±1.16  <0.527
LVEDD (mm)  50.9±3.5 48.8±5.0 46.7±4.6  <0.016
LVESD (mm)  32.6±3.7 30.8±3.3 28.4±3.4  <0.002
IVS (mm)  9.0±1.2 13.0±4.2 14.6±4.2  <0.001
PW (mm)  8.6±1.2 10.0±2.4 10.9±1.5  <0.001
LVEF (%)  68.9±6.4 69.6±3.4 71.2±6.7  <0.464
LA volume index  20.4±4.5 30.5±9.3 29.7±10.6  <0.001
Hypertension, n (%)  7 (38.9)  7 (38.9)  9 (52.9)  <0.308
DM, n (%)  1 (5.6)0 1  (5.6)0 2  (11.1).  <0.808
Dyslipidemia, n (%)  3 (16.7)  3 (16.7)  4 (22.3)  <0.860
BMI (kg/m
2) 24.6±2.8 24.5±2.6 24.3±2.1  <0.960
Exercise duration (sec)  531.2±234.1 519.3±160.5 540.0±186.2  <0.952
Serum collagen markers 
Log ICTP (μ g/L) 0.57±0.24 0.67±0.34 0.54±0.26  <0.322
Log PINP (μ g/L) 1.39±0.29 1.38±0.41 1.71±0.25  <0.003
Log PIIINP (μ g/L) 0.57±0.28 0.60±0.42 0.57±0.21  <0.960
Log PINP/ICTP ratio  0.81±0.41 0.71±0.31 1.18±0.13  <0.001
Log PIIINP/ICTP ratio  -0.00±0.31  -0.06±0.37 0.03±0.32  <0.726
BSA: body surface area, LVEDD: left ventricular end-diastolic dimension, LVESD: left ventricular end-systolic dimension, IVS: interventricular
septum, PW: posterior wall, LVEF: left ventricular ejection fraction, LV: left ventricular, LA: left atrium, DM: diabetes mellitus, BMI: body mass
index, ICTP: collagen type I pyridinoline cross-linked C-terminal telopeptide, PINP: procollagen type 1 N-terminal peptide, PIIINP: procollagen
type III amino terminal peptide, HCM: hypertrophic cardiomyopathy    
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Left ventricular diastolic function at rest 
As shown in Table 3, Doppler echocardiographic pa-
rameters were compared at rest and each stage of exercise 
between the three groups. At rest, the E’ velocity was sig-
nificantly lower in the patients with HCM as compared 
with the control subjects. Interestingly, the HCM group 
with a higher PINP/ICTP revealed lower E’ velocities, a 
higher E/E’ ratio, and lower S’ velocities than the HCM 
Table 3. Comparison of Doppler echo variables at rest and during exercise in the study groups
HCM (n=36) 
  Control (n=21) 
Low PINP/ICTP (n=18)  High PINP/ICTP (n=18) 
p 
E (cm/sec)  Rest  62.9±13.1 57.9±13.1 67.4±24.0  <0.268
 25  W  95.5±19.6 83.9±17.1 92.3±24.7  <0.232
 50  W  110.8±19.2 95.8±21.5 101.8±24.3  <0.163
A (cm/sec)  Rest  68.2±17.1 54.4±12.5 62.8±15.0  <0.022
 25  W  90.1±17.1 75.1±18.0 83.1±19.7  <0.054
 50  W  102.3±18.8 87.6±14.0 92.9±22.8  <0.102
E’ (cm/sec)  Rest  6.0±1.5 4.8±1.2 4.3±1.1  <0.001
 25  W  7.8±1.8 6.1±1.7 5.7±1.3  <0.001
 50  W  8.7±2.5 6.3±1.4 6.4±1.6  <0.002
E/E’ Rest 10.9±2.5 12.8±4.5 16.3±8.2  <0.012
 25  W  12.8±2.9 14.6±4.8 17.0±7.0  <0.058
 50  W  13.5±4.1 15.3±3.1 17.0±7.0  <0.177
SV (mL)  Rest  60.6±14.2 66.8±18.9 66.4±13.9  <0.497
 25  W  66.7±18.4 70.7±18.4 68.3±18.0  <0.853
 50  W  68.1±12.2 71.3±21.5 67.4±13.2  <0.840
Ed Rest  0.19±0.04 0.18±0.03 0.22±0.05  <0.112
 25  W  0.20±0.08 0.18±0.07 0.24±0.05  <0.278
 50  W  0.20±0.06 0.21±0.06 0.22±0.05  <0.774
S’ (cm/sec)  Rest  6.8±0.9 6.1±1.2 5.8±0.8  <0.011
 25  W  7.8±1.1 6.8±1.2 6.3±1.3  <0.003
 50  W  8.7±1.6 7.5±1.5 7.1±1.3  <0.005
 Peak  9.5±2.3 8.0±1.8 8.4±3.3  <0.179
Change in E’  Rest to 25 W  1.8±1.3 1.2±1.5 1.3±1.3  <0.461
  Rest to 50 W  2.9±2.5 1.5±1.2 2.1±1.4  <0.141
Change in E/E’  Rest to 25 W  1.5±2.7 1.4±5.0 1.5±3.3  <0.990
  Rest to 50 W  1.8±2.4 1.3±4.5 0.1±4.7  <0.488
Change in S’  Rest to 25 W  1.0±1.3 0.7±1.3 0.5±1.2  <0.515
  Rest to 50 W  2.0±1.8 1.2±1.7 1.2±1.1  <0.300
  Rest to Peak  2.8±2.6 1.8±1.8 2.5±3.0  <0.522
E: early diastolic mitral inflow velocity, A: late diastolic mitral inflow velocity, E’: early diastolic mitral annular velocity, SV: stroke volume, Ed: dias-
tolic elastance, S’: systolic mitral annular velocity, HCM: hypertrophic cardiomyopathy, PINP: procollagen type 1 N-terminal peptide, ICTP: colla-
gen type I pyridinoline cross-linked C-terminal telopeptide   
Table 2. Hemodynamic response to exercise 
HCM (n=36) 
  Control (n=21) 
Low PINP/ICTP (n=18)  High PINP/ICTP (n=18) 
p 
Systolic BP at rest (mmHg)  126.8±16.8 120.4±21.0 120.9±23.1 0.544
Systolic BP at 25 W (mmHg)  150.1±21.6 140.0±24.4 154.1±32.1 0.289
Systolic BP at 50 W (mmHg)  161.9±22.6 156.2±26.9 156.1±22.9 0.728
Diastolic BP at rest (mmHg)  74.9±11.3 72.7±11.8 71.2±9.3 0.568
Diastolic BP at 25 W (mmHg)  86.0±9.5 80.8±16.5 87.9±14.6 0.311
Diastolic BP at 50 W (mmHg)  87.7±8.0 85.9±11.8 88.1±12.5 0.839
Heart rate at rest (bpm)  63.2±8.4 58.8±8.6 58.9±6.7 0.144
Hear rate at 25 W (bpm)  93.2±14.5 91.3±15.9 91.5±12.2 0.900
Heart rate at 50 W (bpm)  108.0±13.9 102.5±16.4 104.0±13.4 0.514
HCM: hypertrophic cardiomyopathy, PINP: procollagen type 1 N-terminal peptide, ICTP: collagen type I pyridinoline cross-linked C-terminal
telopeptide, BP: blood pressure, bpm: beats per minute 
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group with lower PINP/ICTP. From these results, we 
know that the left ventricular longitudinal diastolic and 
systolic function at rest were significantly impaired in pa-
tients with HCM who had a higher PINP/ICTP ratio.   
 
Left ventricular diastolic function with exercise 
At each stage of exercise, the E’ velocity, E/E’ ratio, 
and S’ velocity were significantly lower in the HCM 
group than the control group, and the values were ele-
vated to a similar extent during exercise. Thus, the mag-
nitude of changes in E’ velocity, E/E’, and S’ velocity 
from rest to each stage of exercise was not different be-
tween the three groups. Therefore, the presence of HCM 
or the higher PINT/ICTP ratio were not associated with 
a significant decrease in diastolic functional reserve dur-
ing exercise, even though there was significant left ven-
tricular diastolic dysfunction at rest. 
 
Discussion 
 
The principle findings of this study are as follows: 1) 
in patients with HCM, the concentration of serum bio-
chemical markers indicating myocardial fibrosis was ele-
vated, and the left ventricular diastolic function at rest 
was significantly impaired; and 2) although the serum 
biochemical markers indicating myocardial fibrosis was 
elevated in patients with HCM, it remained unclear whe-
ther the left ventricular diastolic functional reserve was 
more impaired during exercise. 
In patients with HCM, the left ventricular diastolic 
dysfunction is the most important feature and it has been 
known as a major determinant of a patient’s symptoms.
18) 
The left ventricular diastolic function is determined by 
the degree of myocardial hypertrophy and interstitial 
fibrosis. In the normal heart, the intersitial tissue is com-
posed of types I and III collagen. Type I collagen was 
abundantly present at a ratio of 70 : 30 and it is charac-
terized by a higher degree of rigidity.
19) In patients with 
HCM, due to the presence of myocardial fibrosis, col-
lagen is increased by approximately 20% of the total 
volume of the myocardium.
20) According to this study, 
type 3 collagen did not show a significant difference in 
the HCM groups as compared with the control group. 
Type I collagen and the indicator for the turnover of type 
I collagen, PINP/CITP in the HCM groups, was high-
er than the control group. Especially, the patients with 
HCM with a higher PINP/CITP ratio had a larger sep-
tal thickness, decreased diastolic and systolic longitudi-
nal parameters, and increased E over E’, indicating a 
higher left ventricular filling pressure in this group. The 
differences in these parameters were consistent at rest 
and at each stage of exercise.   
A microscopic examination based on the endomyo-
cardial biopsy has been considered as the most accurate, 
standard test for the diagnosis of myocardial fibrosis. But, 
this diagnostic method requires an invasive procedure 
and there are also limitations that a partial tissue sample 
of endomyocardium which is obtained from the right 
ventricle cannot accurately reflect the heterogeneity of 
myocardial fibrosis in the left ventricle. The type I colla-
gen synthesis-to-degradation ratio, a turnover marker of 
type I collagen, could estimate the degree of myocardial 
fibrosis simply with non-invasive serologic tests. Lom-
bardi et al.
6) demonstrated a higher collagen turnover in 
36 patients with HCM compared with 14 age- and gen-
der-matched controls. In the study, the left ventricular 
diastolic dysfunction was assessed by the pulse-wave Dop-
pler parameters of mitral inflow and pulmonic vein flow. 
In the present study, we also assessed the left ventricular 
longitudinal diastolic function by tissue Doppler imag-
ing. From the tissue velocities on the mitral septal annu-
lus, the E’ and S’ velocities could be obtained, then the 
E over E’ ratio calculated, indicating the left ventricular 
filling pressure. 
The aim of this study was to prove the hypothesis that 
a higher level of serologic markers indicating collagen 
turnover would show a reduced diastolic functional re-
serve during exercise within the HCM group. However, 
although the patients with HCM with a higher collagen 
turnover had significant diastolic dysfunction at rest, there 
were no significant differences in the degree of changes 
in diastolic parameters during exercise as compared with 
the patients with HCM with a lower collagen turnover. 
Therefore, we conclude that a higher collagen turnover 
ratio in patients with HCM is not associated with left 
ventricular diastolic functional reserve in this study pop-
ulation. 
The limitations of the current study were as follows: 1) 
In patients with HCM with a higher collagen turnover 
marker, there were significantly lower E’ and S’ velo-
cities from the resting status. Because of these resting dif-
ferences in the diastolic and systolic tissue parameters, it 
might be inappropriate to confirm the difference in dia-
stolic function reserve during exercise. To prove the dif-
ferent changes in diastolic function according to exercise, 
it is preferable that the subjects have similar profiles of 
E’ velocity, S’ velocity, and E over E’ at rest. 2) This study 
was limited by the small number of enrolled subjects. 3) 
This study did not consider the effects of cardiovascular 
medications which could affect the degree of myocardial 
fibrosis. 
In conclusion, the non-invasive serologic test of type 
I collagen turnover (the PINP/ICTP ratio) was associ-
ated with resting diastolic dysfunction in patients with 
HCM. However, there was no relationship with augment-
ed diastolic dysfunction during exercise. Therefore, we 
suggest that the type I collagen synthesis-to-degradation 
ratio will be a useful marker of resting diastolic function 
in patients with HCM. Further studies are warranted to 
examine the diastolic functional reserve with exercise in  
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patients with HCM with relatively well-preserved dia-
stolic function at rest.   
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